当前位置: X-MOL 学术Eur. J. Heart Fail. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Use of guideline-recommended medical therapy in patients with heart failure and chronic kidney disease: from physician's prescriptions to patient's dispensations, medication adherence and persistence
European Journal of Heart Failure ( IF 18.2 ) Pub Date : 2022-07-18 , DOI: 10.1002/ejhf.2620
Roemer J Janse 1, 2 , Edouard L Fu 1, 2, 3 , Ulf Dahlström 4 , Lina Benson 5 , Bengt Lindholm 6 , Merel van Diepen 2 , Friedo W Dekker 2 , Lars H Lund 5, 7 , Juan-Jesus Carrero 1, 8 , Gianluigi Savarese 5, 7
Affiliation  

Half of heart failure (HF) patients have chronic kidney disease (CKD) complicating their pharmacological management. We evaluated physicians' and patients' patterns of use of evidence-based medical therapies in HF across CKD stages.

中文翻译:

指南推荐的药物治疗在心力衰竭和慢性肾脏病患者中的应用:从医生处方到患者配药、药物依从性和坚持性

一半的心力衰竭 (HF) 患者患有慢性肾脏疾病 (CKD),这使得他们的药物管理变得复杂。我们评估了医生和患者在 CKD 各阶段使用循证医学疗法治疗 HF 的模式。
更新日期:2022-07-18
down
wechat
bug